P

PubMedAI

EVE Evidence Analyzer

Patent Pending

17%20alpha%20hydroxyprogesterone%20caproate

a PROGESTIN and is used to reduce the risk of recurrent MISCARRIAGE and of PREMATURE BIRTH. It is also used in combination with ESTROGEN in the management of MENSTRUATION DISORDERS.

287 PubMed studies analyzed
Loading evidence profile...

This evidence profile for 17%20alpha%20hydroxyprogesterone%20caproate is generated deterministically from 287 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.